AI-driven discovery and validation of a GIPC1 PDZ domain inhibitor for pancreatic ductal adenocarcinoma

27

AI-driven discovery and validation of a GIPC1 PDZ domain inhibitor for pancreatic ductal adenocarcinoma

Tags:

Previous Article

Somatic mutations reveal the ontogeny of human microglia

AI designed small molecule inhibitor against pancreatic cancer

Related Posts

Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy

Cancer-induced nerve injury promotes resistance to anti...

114

Genetics of Alzheimer’s disease: where we are, and where we are going

Genetics of Alzheimer’s disease: where we are, and wher...

148

Intermittent fasting triggers interorgan communication to suppress hair follicle regeneration

Intermittent fasting triggers interorgan communication ...

108